Results 131 to 140 of about 15,285 (179)

Comparison between intermittent claudication versus chronic limb-threatening ischemia in peripheral arterial disease: a retrospective multicenter cohort study. [PDF]

open access: yesAnn Surg Treat Res
Woo HY   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Intermittent claudication

Nursing Standard, 2003
Intermittent claudication is a painful, debilitating condition that reduces mobility in those affected and has a detrimental effect on quality of life. It is often the first symptom of peripheral arterial disease. This article explains the aetiology of intermittent claudication, the associated risk factors, vascular assessment and the nursing care ...
openaire   +2 more sources

Intermittent Claudication — Be Conservative

New England Journal of Medicine, 1991
Severe peripheral vascular disease is a common disorder that frequently creates substantial morbidity in our aging population.
Jay D Coffman, J D Coffman
exaly   +3 more sources

[Intermittent claudications].

Journal des maladies vasculaires, 2005
International ...
Becker, F.   +14 more
openaire   +2 more sources

Pharmacotherapy of intermittent claudication

Expert Opinion on Pharmacotherapy, 2001
Intermittent claudication (IC) is leg muscle pain, cramping and fatigue brought on by exercise and is the primary symptom of peripheral arterial disease. The goals of pharmacotherapy for IC are to increase the walking capacity/quality of life and to decrease rates of amputation.
openaire   +5 more sources

Pentoxifylline for intermittent claudication

2005
Intermittent claudication (IC) is a symptom of peripheral arterial occlusive disease (PAD). It is associated with high morbidity and mortality. Pentoxifylline is one of many drugs used to treat IC. Pentoxifylline decreases blood viscosity, improves erythrocyte flexibility, and increases microcirculatory flow and tissue oxygen concentration.Many studies
Kareem, Salhiyyah   +4 more
openaire   +2 more sources

Prostanoids for intermittent claudication

Cochrane Database of Systematic Reviews, 2013
BackgroundPeripheral arterial disease (PAD) is a common cause of morbidity in the general population. While numerous studies have established the efficacy of prostanoids in PAD stages III and IV, the question of the role of prostanoids as an alternative or additive treatment in patients suffering from intermittent claudication (PAD II) has not yet been
Lindsay, Robertson, Alina, Andras
openaire   +2 more sources

Home - About - Disclaimer - Privacy